Annex Advisory Services, LLC Amgen Inc Transaction History

Annex Advisory Services, LLC

$2.76 Billion
Q3 2024

A detailed history of Annex Advisory Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Annex Advisory Services, LLC holds 17,795 shares of AMGN stock, worth $4.69 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

17,795

Previous 18,131 1.85%

Holding current value

$4.69 Million

Previous $5.67 Million 1.2%

% of portfolio

0.21%

Previous 0.21%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $103,951 - $113,359	-336 Reduced 1.85%	17,795 $5.73 Million
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $798,760 - $970,702	3,040 Added 20.14%	18,131 $5.67 Million
Q1 2024 Apr 12, 2024	BUY	$268.87 - $324.56 $76,627 - $92,499	285 Added 1.92%	15,091 $4.29 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $3.79 Million - $4.27 Million	14,806 New	14,806 $4.26 Million
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $200,630 - $254,924	876 New	876 $230,000
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $197,026 - $219,255	854 New	854 $208,000
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $187,742 - $214,854	-944 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $2.86 Million - $3.35 Million	-13,457 Reduced 93.44%	944 $201,000
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $153,462 - $170,254	657 Added 4.78%	14,401 $3.51 Million
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $169,539 - $197,570	764 Added 5.89%	13,744 $3.42 Million
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $147,354 - $175,473	681 Added 5.54%	12,980 $2.98 Million
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $4,693 - $5,219	20 Added 0.16%	12,299 $3.13 Million
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $123,235 - $151,227	623 Added 5.34%	12,279 $2.9 Million
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $186,067 - $246,775	1,021 Added 9.6%	11,656 $2.36 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $58.9 Million - $75.7 Million	-311,411 Reduced 96.7%	10,635 $2.56 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $59 Million - $75.8 Million	311,832 Added 3052.99%	322,046 $3.55 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $46,661 - $55,910	268 Added 2.69%	10,214 $1.98 Million
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $10,835 - $12,701	-65 Reduced 0.65%	9,946 $1.83 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $26,407 - $29,766	-146 Reduced 1.44%	10,011 $1.9 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $120,955 - $141,193	678 Added 7.15%	10,157 $1.98 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $84,677 - $95,462	457 Added 5.07%	9,479 $1.97 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $95,478 - $107,243	575 Added 6.81%	9,022 $1.67 Million
Q1 2018 May 03, 2018	BUY	$169.43 - $198.0 $151,978 - $177,606	897 Added 11.88%	8,447 $1.44 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $67,178 - $75,058	398 Added 5.56%	7,550 $1.31 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $1.2 Million - $1.37 Million	7,152	7,152 $1.33 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annex Advisory Services, LLC with notifications on news.

Account

Annex Advisory Services, LLC Amgen Inc Transaction History